Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

The roles and therapeutic potential of distinct dystrophin and utrophin isoforms in the central and peripheral nervous system

2021/43/B/NZ5/00723

Keywords:

Duchenne muscular dystrophy (DMD) dystrophin utrophin recombinant adeno-associated viral (rAAV) vectors central nervous system peripheral nervous system neurons astrocytes oligodendrocytes microglia Schwann cells

Descriptors:

  • NZ5_003:
  • NZ5_007:

Panel:

NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)

Host institution :

Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii

woj. wielkopolskie

Other projects carried out by the institution 

Principal investigator (from the host institution):

dr hab. Patryk Konieczny 

Number of co-investigators in the project: 5

Call: OPUS 22 - announced on 2021-09-15

Amount awarded: 2 533 452 PLN

Project start date (Y-m-d): 2022-10-03

Project end date (Y-m-d): 2027-10-02

Project duration:: 60 months (the same as in the proposal)

Project status: Pending project

Project description

Download the project description in a pdf file

Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

  • Publication in academic press/journals (2)
  1. Systemic Treatment of Body-Wide Duchenne Muscular Dystrophy Symptoms
    Authors:
    Patryk Konieczny
    Academic press:
    Clinical Pharmacology and Therapeutics (rok: 2024, tom: 116, strony: 1472-1484), Wydawca: Wiley-Blackwell
    Status:
    Published
    DOI:
    10.1002/cpt.3363 - link to the publication
  2. Dystrophin- and Utrophin-Based Therapeutic Approaches for Treatment of Duchenne Muscular Dystrophy: A Comparative Review
    Authors:
    Sylwia Szwec, Zuzanna Kapłucha, Jeffrey S. Chamberlain, Patryk Konieczny
    Academic press:
    BioDrugs (rok: 2024, tom: 38, strony: 95-119), Wydawca: ADIS INT LTD
    Status:
    Published
    DOI:
    10.1007/s40259-023-00632-3 - link to the publication